| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 400 |
| 1 | OLANZAPINE | 131 |
| 2 | LITHIUM CARBONATE | 110 |
| 3 | LITHIUM | 106 |
| 4 | LITHIUM BROMATUM | 106 |
| 5 | ARIPIPRAZOLE | 92 |
| 6 | QUETIAPINE | 89 |
| 7 | RISPERIDONE | 80 |
| 8 | ARIPIPRAZOLE ORAL | 72 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMISULPRIDE | 56 | 0.0091 |
| 1 | LITHIUM CARBONATE | 110 | 0.0064 |
| 2 | EPHEDRINE HYDROCHLORIDE | 2 | 0.0044 |
| 3 | LITHIUM | 106 | 0.0042 |
| 4 | RIFABUTIN | 11 | 0.0040 |
| 5 | CLOZAPINE | 400 | 0.0032 |
| 6 | HALOPERIDOL DECANOATE | 5 | 0.0029 |
| 7 | BENZTROPINE | 19 | 0.0026 |
| 8 | ZIPRASIDONE | 8 | 0.0022 |
| 9 | FLUVOXAMINE MALEATE | 5 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 592 |
| 1 | Benzodiazepine [EPC] | 134 |
| 2 | Mood Stabilizer [EPC] | 71 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 4 | Anti-epileptic Agent [EPC] | 62 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 57 |
| 6 | Proton Pump Inhibitor [EPC] | 51 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 27 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 25 |
| 9 | Calcium Channel Blocker [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 57 | 0.0073 |
| 1 | Rifamycin Antimycobacterial [EPC] | 11 | 0.0031 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 6 | 0.0019 |
| 3 | Atypical Antipsychotic [EPC] | 592 | 0.0013 |
| 4 | Typical Antipsychotic [EPC] | 22 | 0.0009 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 3 | 0.0008 |
| 6 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 7 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 8 | Antimycobacterial [EPC] | 11 | 0.0005 |
| 9 | Mood Stabilizer [EPC] | 71 | 0.0003 |